[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ying Liu\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100372519",false,"NCT04130464","Intraperitoneal Infusion of Analgesic for Postoperative Pain Management","The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial","ON-Q","Inclusion Criteria:\n\n* Hysterectomy planned for a benign gynecologic reason (no evidence of, or concern for, malignancy in the cervix, uterus, tubes or ovaries. Benign gynecologic reasons to have a hysterectomy include fibroids, abnormal uterine bleeding, endometriosis, and pelvic pain.)\n* Patient is scheduled to have surgery with a fellowship trained minimally invasive gynecologic surgeons at one of the study sites.\n* Patient is planned for a robotic assisted total laparoscopic hysterectomy (RA-TLH) or a total laparoscopic hysterectomy (TLH).\n* Patient is capable of informed consent.\n* Patient is capable of completing the questionnaires.\n\nExclusion Criteria:\n\n* Concern for malignancy\n* The procedure is scheduled outside MIGS department.\n* Allergy to any study related medication (i.e. Ketorolac and Ropivacaine)\n* Patient is enrolled in another pain management study.",true,"FEMALE","18 Years","65 Years",{"count":21,"type":22},120,"ESTIMATED","INTERVENTIONAL",[25],"PHASE4","The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.",[28,29,30,31],"Hysterectomy","Gynecologic Surgical Procedures","Narcotic Use","Pain, Postoperative",[33,34,35,36],"Intraperitoneal","Pain Pump","Ropivacaine","Ketorolac Tromethamine","RECRUITING","2026-04-03",{"date":40,"type":41},"2026-04-09","ACTUAL",{"date":43,"type":41},"2019-09-30",{"date":45,"type":22},"2026-12",{"name":47,"class":48},"Ying Liu","OTHER",2,""]